CADLCandel Therapeutics, Inc.Basing

TodayBasingjumpy stock

Nasdaq GMBiotechnologyMarket cap $596.08MReports Nov 12, 2026

Candel Therapeutics, Inc.

Oncology
Sector
Healthcare
Industry
Biotechnology
Market cap
$596.08M
Employees
55
Exchange
Nasdaq GM
Country
United States
7.79−2.99% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Basing, stage 1 of 4, 2 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages and momentum readings are washed out: recent selling pressure has been heavy. RSI is currently 27.

Readings, end-of-day Oct 26, 2026
RSI (14)Oversold zone26.75, flagged reading
MACD / signalBelow signal line-0.81 / -0.72, caution reading
SMA 50Price below11.00, caution reading
SMA 200Price below8.23, caution reading
EMA 20Price below9.19, caution reading
ADX (14)Trending37.29
Show all 12 readings
+DI / −DI−DI leading9.95 / 30.83, caution reading
ATR (14)6.5% of price — elevated daily swings0.51, flagged reading
Stochastic %KOversold zone1.85, flagged reading
Bollinger bands (20)Inside bands7.44 – 11.14
ROC (10)Negative over 10 sessions-20.35, caution reading
Trend / momentum impulseTrend and momentum agreeBoth falling, caution impulse reading
Full analysis

What unlocking CADL reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when CADL's analysis runs, rather than checked against its stored data now.

Every section above, argued on CADL's own numbers, on one page.

See what CADL costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full CADL analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get CADL + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Candel Therapeutics, Inc. report earnings?

Candel Therapeutics, Inc. (CADL) is scheduled to report earnings on Nov 12, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock CADL